Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1986 May;52(2):594–599. doi: 10.1128/iai.52.2.594-599.1986

Polyclonal activation of rat splenic lymphocytes after in vivo administration of Mycoplasma pulmonis and its relation to in vitro response.

J S Williamson, J K Davis, G H Cassell
PMCID: PMC261042  PMID: 3486159

Abstract

The plaque-forming cell (PFC) assay with sheep erythrocytes (SRBC) sensitized with different antigens and a 4-h tritiated thymidine pulse assay were used to determine whether polyclonal activation occurs in rats following in vivo administration of Mycoplasma pulmonis. Injection of M. pulmonis into F344 rats resulted in an increase in the number of splenic immunoglobulin M-secreting PFC that produced antibodies reactive with the trinitrophenyl hapten and with SRBC. This polyclonal response reached a peak by 72 h after injection and returned to normal levels by 96 h, at which time the specific response to M. pulmonis reached its peak. Heat treatment and preopsonization of M. pulmonis with antiserum before injection resulted in reduced numbers of PFC against M. pulmonis-sensitized SRBC, trinitrophenyl hapten-sensitized SRBC, and SRBC. The number of PFC against the three types of target cells also increased in LEW rats after immunization with M. pulmonis. The number of PFC against SRBC and staphylococcal protein A-sensitized SRBC was higher in immunized LEW rats than in immunized F344 rats. Examination of unimmunized animals also revealed that LEW rats had higher initial numbers of PFC than did F344 rats. These results showed that polyclonal activation occurs in rats following in vivo administration of M. pulmonis and that LEW rats have an inherent propensity to develop higher nonspecific responses in vivo than F344 rats.

Full text

PDF
594

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bice D. E., Degen M. A., Harris D. L., Muggenburg B. A. Recruitment of antibody-forming cells in the lung after local immunization is nonspecific. Am Rev Respir Dis. 1982 Oct;126(4):635–639. doi: 10.1164/arrd.1982.126.4.635. [DOI] [PubMed] [Google Scholar]
  2. Cassell G. H., Davis J. K. Protective effect of vaccination against Mycoplasma pulmonis respiratory disease in rats. Infect Immun. 1978 Jul;21(1):69–75. doi: 10.1128/iai.21.1.69-75.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cassell G. H., Lindsey J. R., Davis J. K., Davidson M. K., Brown M. B., Mayo J. G. Detection of natural Mycoplasma pulmonis infection in rats and mice by an enzyme linked immunosorbent assay (ELISA). Lab Anim Sci. 1981 Dec;31(6):676–682. [PubMed] [Google Scholar]
  4. Davis J. K., Cassell G. H. Murine respiratory mycoplasmosis in LEW and F344 rats: strain differences in lesion severity. Vet Pathol. 1982 May;19(3):280–293. doi: 10.1177/030098588201900306. [DOI] [PubMed] [Google Scholar]
  5. Davis J. K., Parker R. F., White H., Dziedzic D., Taylor G., Davidson M. K., Cox N. R., Cassell G. H. Strain differences in susceptibility to murine respiratory mycoplasmosis in C57BL/6 and C3H/HeN mice. Infect Immun. 1985 Dec;50(3):647–654. doi: 10.1128/iai.50.3.647-654.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Davis J. K., Simecka J. W., Williamson J. S., Ross S. E., Juliana M. M., Thorp R. B., Cassell G. H. Nonspecific lymphocyte responses in F344 and LEW rats: susceptibility to murine respiratory mycoplasmosis and examination of cellular basis for strain differences. Infect Immun. 1985 Jul;49(1):152–158. doi: 10.1128/iai.49.1.152-158.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Davis J. K., Thorp R. B., Maddox P. A., Brown M. B., Cassell G. H. Murine respiratory mycoplasmosis in F344 and LEW rats: evolution of lesions and lung lymphoid cell populations. Infect Immun. 1982 May;36(2):720–729. doi: 10.1128/iai.36.2.720-729.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kanowith-Klein S., Vitetta E. S., Ashman R. F. The isotype cycle: successive changes in surface immunoglobulin classes expressed by the antigen-binding B-cell population during the primary in vivo response. Cell Immunol. 1981 Aug;62(2):377–384. doi: 10.1016/0008-8749(81)90338-5. [DOI] [PubMed] [Google Scholar]
  9. Keystone E. C., Cunningham A. J., Metcalfe A., Kennedy M., Quinn P. A. Role of antibody in the protection of mice from arthritis induced by Mycoplasma pulmonis. Clin Exp Immunol. 1982 Feb;47(2):253–259. [PMC free article] [PubMed] [Google Scholar]
  10. Larsen G. L., Parrish D. A., Henson P. M. Lung defense. The paradox of inflammation. Chest. 1983 May;83(5 Suppl):1S–5S. [PubMed] [Google Scholar]
  11. Lindsey J. R., Baker H. J., Overcash R. G., Cassell G. H., Hunt C. E. Murine chronic respiratory disease. Significance as a research complication and experimental production with Mycoplasma pulmonis. Am J Pathol. 1971 Sep;64(3):675–708. [PMC free article] [PubMed] [Google Scholar]
  12. Naot Y., Davidson S., Lindenbaum E. S. Mitogenicity and pathogenicity of Mycoplasma pulmonis in rats. I. Atypical interstitial pneumonia induced by mitogenic myeoplasmal membranes. J Infect Dis. 1981 Jan;143(1):55–62. doi: 10.1093/infdis/143.1.55. [DOI] [PubMed] [Google Scholar]
  13. Naot Y. In vitro studies on the mitogenic activity of mycoplasmal species toward lymphocytes. Rev Infect Dis. 1982 May-Jun;4 (Suppl):S205–S209. doi: 10.1093/clinids/4.supplement_1.s205. [DOI] [PubMed] [Google Scholar]
  14. Naot Y., Merchav S., Ben-David E., Ginsburg H. Mitogenic activity of Mycoplasma pulmonis. I. Stimulation of rat B and T lymphocytes. Immunology. 1979 Mar;36(3):399–406. [PMC free article] [PubMed] [Google Scholar]
  15. Naot Y., Siman-Tov R., Ginsburg H. Mitogenic activity of Mycoplasma pulmonis. II. Studies on the biochemical nature of the mitogenic factor. Eur J Immunol. 1979 Feb;9(2):149–154. doi: 10.1002/eji.1830090211. [DOI] [PubMed] [Google Scholar]
  16. Parker D. C. Separable helper factors support B cell proliferation and maturation to Ig secretion. J Immunol. 1982 Aug;129(2):469–474. [PubMed] [Google Scholar]
  17. Rittenberg M. B., Pratt K. L. Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb/c mice to soluble and particulate immunogen. Proc Soc Exp Biol Med. 1969 Nov;132(2):575–581. doi: 10.3181/00379727-132-34264. [DOI] [PubMed] [Google Scholar]
  18. UHR J. W., BAUMANN J. B. Antibody formation. I. The suppression of antibody formation by passively administered antibody. J Exp Med. 1961 May 1;113:935–957. doi: 10.1084/jem.113.5.935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Uhr J. W., Möller G. Regulatory effect of antibody on the immune response. Adv Immunol. 1968;8:81–127. doi: 10.1016/s0065-2776(08)60465-4. [DOI] [PubMed] [Google Scholar]
  20. Weigle W. O. Cyclical production of antibody as a regulatory mechanism in the immune response. Adv Immunol. 1975;21:87–111. doi: 10.1016/s0065-2776(08)60219-9. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES